Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Orlistat on Body Composition vs Placebo in Overweight and Obese Adults
2008-003395-22Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and Overweight comparing Orlistat with Placebo (2 arms). Primary endpoint: Abdominal visceral adipose tissue mass change from baseline to week 24. Started Jul 2008; status: completed.
02
Drugs
orlistat
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on 2008-003395-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003395-22.